Literature DB >> 17600614

Clinicopathologic features of prostate adenocarcinoma incidentally discovered at the time of radical cystectomy: an evidence-based analysis.

Rocco Damiano1, Giuseppe Di Lorenzo, Francesco Cantiello, Marco De Sio, Sisto Perdonà, Massimo D'Armiento, Riccardo Autorino.   

Abstract

OBJECTIVES: To review all relevant features of incidentally discovered prostate cancer (PCa) in patients undergoing radical cystectomy for bladder cancer: incidence, pathologic characteristics, clinical significance, and implications for its management.
METHODS: A structured literature review through a MEDLINE search was performed.
RESULTS: The frequency of incidentally discovered PCa in cystoprostatectomy specimens is extremely variable because of several factors, particularly the pathology sampling. The relationship among clinically, incidentally, and autopsy-detected cancer is uncertain. The definition of clinically significant cancer varies among published reports and remains inadequate for clinical application. High-grade prostatic intraepithelial neoplasia is a marker for concurrent PCa and the risk depends more on the volume than on its absolute presence. Outcome of patients with unsuspected PCa after cystoprostatectomy relies mostly on the bladder tumor.
CONCLUSIONS: Incidental PCa in patients with bladder cancer is highly variable and with an unclear clinical significance. For those who are candidates for prostate-sparing surgery, it seems reasonable to include a routine prostate biopsy in the standard preoperative work-up irrespective of prostate-specific antigen values. In the absence of sufficient data to make firm recommendations, when PCa is incidentally discovered, PCa surveillance should be part of the follow-up scheme after radical cystectomy. European Association of Urology

Entities:  

Mesh:

Year:  2007        PMID: 17600614     DOI: 10.1016/j.eururo.2007.06.016

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  18 in total

Review 1.  [Treatment of bladder cancer. Value of radical prostate-sparing cystectomy].

Authors:  A Heidenreich; D Porres; D Pfister
Journal:  Urologe A       Date:  2012-06       Impact factor: 0.639

2.  Prevalence of incidental prostate cancer in patients undergoing radical cystoprostatectomy: data from China and other Asian countries.

Authors:  Yi-Ping Zhu; Ding-Wei Ye; Xu-Dong Yao; Shi-Lin Zhang; Bo Dai; Hai-Liang Zhang; Yi-Jun Shen; Yao Zhu; Guo-Hai Shi
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

3.  Clinical Significance of Incidental Prostatic Carcinoma on Radical Cystectomy Histology Specimens: a Clinicopathological and Survival Analysis.

Authors:  Dharma Ram; Suhas K Rajappa; Sudhir Rawal; Amitabh Singh; Kailash Chand Sharma; Ajay Kumar Dewan
Journal:  Indian J Surg Oncol       Date:  2018-04-21

4.  Incidental prostate cancer prevalence at radical cystoprostatectomy--importance of the histopathological work-up.

Authors:  C Wetterauer; M Weibel; J R Gsponer; T Vlajnic; T Zellweger; S Bütikofer; G Müller; H Püschel; A Bachmann; T C Gasser; L Bubendorf; C A Rentsch
Journal:  Virchows Arch       Date:  2014-10-01       Impact factor: 4.064

5.  Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.

Authors:  H M Fritsche; A Aziz; F Eder; W Otto; S Denzinger; W F Wieland; M May; F Hofstädter; A Hartmann; M Burger
Journal:  Virchows Arch       Date:  2012-10-09       Impact factor: 4.064

Review 6.  Concomitant bladder cancer and prostate cancer: challenges and controversies.

Authors:  Antonio Lopez-Beltran; Liang Cheng; Francesco Montorsi; Maria Scarpelli; Maria R Raspollini; Rodolfo Montironi
Journal:  Nat Rev Urol       Date:  2017-08-16       Impact factor: 14.432

7.  Concomitant Gleason Score ≥ 7 prostate cancer is an independent prognosticator for poor survival in nonmetastatic bladder cancer patients undergoing radical cystoprostatectomy.

Authors:  Christian Thomas; Alexander Giesswein; Michael Hainz; Raimund Stein; Peter Rubenwolf; Frederik C Roos; Andreas Neisius; Sebastian Nestler; Christian Hampel; Wolfgang Jäger; Christoph Wiesner; Joachim W Thüroff
Journal:  Int Urol Nephrol       Date:  2015-09-16       Impact factor: 2.370

8.  Preoperative findings, pathological stage PSA recurrence in men with prostate cancer incidentally detected at radical cystectomy: our experience in 242 cases.

Authors:  Pietro Pepe; Filippo Fraggetta; Antonio Galia; Paolo Panella; Michele Pennisi; Maurizio Colecchia; Francesco Aragona
Journal:  Int Urol Nephrol       Date:  2014-02-01       Impact factor: 2.370

Review 9.  Defining the threshold for significant versus insignificant prostate cancer.

Authors:  Theo H Van der Kwast; Monique J Roobol
Journal:  Nat Rev Urol       Date:  2013-05-28       Impact factor: 14.432

Review 10.  Overdiagnosis in urologic cancer : For World Journal of Urology Symposium on active surveillance in prostate and renal cancer.

Authors:  Laurence Klotz
Journal:  World J Urol       Date:  2021-01-25       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.